Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H28O11 |
| Molecular Weight | 516.4939 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)OC[C@H]1O[C@@H](OC2=CC(C)=CC(O)=C2C(=O)CCC3=CC4=C(OC=C4)C=C3)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=BXNCIERBDJYIQT-PRDVQWLOSA-N
InChI=1S/C26H28O11/c1-13-9-17(28)21(16(27)5-3-14-4-6-18-15(11-14)7-8-34-18)19(10-13)36-25-24(31)23(30)22(29)20(37-25)12-35-26(32)33-2/h4,6-11,20,22-25,28-31H,3,5,12H2,1-2H3/t20-,22-,23+,24-,25-/m1/s1
| Molecular Formula | C26H28O11 |
| Molecular Weight | 516.4939 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL4979 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10480610 |
22.8 µM [IC50] | ||
Target ID: CHEMBL3884 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10480610 |
2.3 µM [IC50] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:39:03 GMT 2025
by
admin
on
Mon Mar 31 23:39:03 GMT 2025
|
| Record UNII |
94E730CSAF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6918410
Created by
admin on Mon Mar 31 23:39:03 GMT 2025 , Edited by admin on Mon Mar 31 23:39:03 GMT 2025
|
PRIMARY | |||
|
94E730CSAF
Created by
admin on Mon Mar 31 23:39:03 GMT 2025 , Edited by admin on Mon Mar 31 23:39:03 GMT 2025
|
PRIMARY | |||
|
209746-59-8
Created by
admin on Mon Mar 31 23:39:03 GMT 2025 , Edited by admin on Mon Mar 31 23:39:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |